Ophthamalogy Times Europe: ‘LIGHT Trial focuses on lowering IOP, keeping it there’ Professor Gazzard’s work is covered in this piece from November 2019 published in the Ophthamalogy Times Europe magazine. You can read the full article here Previous articleNIHR: Professor Gus Gazzard publishes ground-breaking researchNext article LiGHT: Efficacy and Cost Effectiveness - Eyetube Video
